GlassScriptPhysician profile
Kimberly A Dodson
NPI 1255361192
$1,238.97
in general payments reported to CMS, 2019-2025
10 companies · $291 in 2025
The $291 reported for 2025 was more than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $125 · 2022: $98.40 · 2023: $265 · 2024: $459 · 2025: $291.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,016.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,015.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $247.09 | 2021-2024 | Arexvy |
| Ethicon US, LLC | $245.07 | 2022-2024 | Surgicel Nu-Knit, Surgiflo Hemostatic Matrix, Evarrest |
| Baxter Healthcare | $151.71 | 2023-2024 | Floseal, Tisseel |
| Biomerieux INC | $143.00 | 2024 | Biofire Spotfire Respiratory (R) Panel |
| Actelion Pharmaceuticals US, INC. | $109.62 | 2025 | Uptravi, Opsumit |
| Novo Nordisk INC | $109.62 | 2025 | Wegovy |
| Exact Sciences Corporation | $105.91 | 2023 | Cologuard Collection Kit |
| Cequr Corporation | $71.87 | 2025 | Cequr Simplicity |
| Heron Therapeutics, INC. | $35.00 | 2023 | Zynrelef |
| Teleflex LLC | $20.08 | 2024 | Urolift |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimberly Dodson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.